Bruker BioSciences Reports Significantly Improved Earnings and Cash Flows on Record Revenue of $297.6 Million For Full Year 2005

BILLERICA, Mass.--(BUSINESS WIRE)--Feb. 22, 2006--

Company Reports Four Profitable Quarters and $41 Million Cash Flow from Operations in 2005

Bruker BioSciences Corporation (NASDAQ: BRKR) today reported fourth quarter 2005 revenue of $80.6 million, compared to revenue of $85.6 million in the fourth quarter of 2004. Excluding foreign currency effects, revenue increased by 1%. For the full year 2005, revenue increased 5% to $297.6 million, compared to (...)

Bruker BioSciences Corporation to Release Fourth Quarter and Full Year 2005 Financial Results on February 22, 2006

BILLERICA, Mass.--(BUSINESS WIRE)--Feb. 21, 2006--Bruker BioSciences Corporation (NASDAQ:BRKR) plans to release its fourth quarter and full year 2005 financial results on Wednesday, February 22, 2006 after the market closes. Bruker BioSciences will then host an operator-assisted earnings conference call the following morning, Thursday, February 23, at 11 a.m. EST. To listen to the webcast, investors can go to www.bruker-biosciences.com and click on the (...)

Bruker Daltonics and German Collection of Microorganisms and Cell Cultures (DSMZ) Announce Collaboration on Identification of Microorganisms by MALDI-TOF Mass Spectrometry

BREMEN and BRAUNSCHWEIG, Germany, Feb 21, 2006 (BUSINESS WIRE) -- Bruker Daltonik GmbH and the German Collection of Microorganisms and Cell Cultures (DSMZ) today announced a collaboration for the identification and classification of microorganisms from peptide and protein profiles measured by MALDI-TOF mass spectrometry. The DSMZ uses Bruker Daltonik's novel CLINPROT BioTyper(TM) system to generate protein profiles and to perform the required advanced (...)

Bruker Announces the Designation and Certification of its RAID-M Handheld Chemical Detector Under the SAFETY ACT as an Approved Product for Homeland Security

BILLERICA, Mass.--(BUSINESS WIRE)--Jan. 30, 2006--Bruker Daltonics NBC Detection Corp., an operating company of Bruker BioSciences Corporation (NASDAQ: BRKR), today announces that the Department of Homeland Security has granted Designation and Certification of the RAID-M as an approved product under the Support Anti-terrorism by Fostering Effective Technologies Act of 2002 (the SAFETY Act). The RAID-M received both Designation as a Qualified (...)

Biophotonics International publishes an article by Bruker Daltonics scientists

Biophotonics International published an article by Bruker Daltonics scientists entitled "Protein Analysis Moves into the Fast Lane", describing how MALDI-TOF mass spectrometry imaging improves biomarker research.

The Journal of Biomolecular Techniques publishes a paper by Bruker Daltonik Leipzig scientists

The Journal of Biomolecular Techniques published a paper by Bruker Daltonik Leipzig scientists entitled "Selective Isolation of Glycoproteins and Glycopeptides for MALDI-TOF MS Detection Supported by Magnetic Particles." Glycosylation

is the most common form of posttranslational modification of proteins (50-80%).

The isolation, discovery, and subsequent identification of glycosylated peptides and proteins is becoming more and more important in (...)

New Application Note: Microorganism identification and classification based on MALDI-TOF MS fingerprinting

Bruker Daltonics today announced a new Application Note: Microorganism identification and classification based on MALDI-TOF MS fingerprinting. MALDI-MS is a high throughput and reliable method for the classification and identification of microorganisms. Applications are feasible in clinical diagnostics, environmental, and taxonomical research, or food processing in quality control. The robust method requires minimal sample preparation efforts and life (...)

Bruker Daltonik GmbH, PANATecs GmbH and the University of Goettingen Announce a Development Cooperation for New Molecular Diagnostic Assays for Rheumatoid Arthritis

BREMEN, Tuebingen and GOETTINGEN, Germany--(BUSINESS WIRE)--Dec. 20, 2005--Bruker Daltonik GmbH, the University of Goettingen and German biotech company PANATecs GmbH today announced a new development collaboration in protein biomarker discovery and molecular diagnostics research based on mass spectrometry. PANATecs will apply Bruker Daltonics' CLINPROT(TM) tools for biomarker discovery, profiling and identification in the field of rheumatoid arthritis (...)

The International Journal of Cancer published a paper by German scientists, including Bruker Daltonics' Dr. Katrin Sparbier

December 2005 - The International Journal of Cancer published an "early detection and diagnosis" paper by German scientists, including Bruker Daltonics' Dr. Katrin Sparbier. It is entitled "Expression levels of the putative zinc transporter LIV-1 are associated with a better outcome of breast cancer patients."

The scientists investigated the expression pattern of the breast cancer associated gene LIV-1 on mRNA and protein level in 111 human breast cancer (...)

The winner of our Test-the-PAC campaign has been drawn

We cordially congratulate Mr. Nisse Kalkkinen, Ph.D., laboratory director Protein Chemistry Research Group and Core Facility Institute of Biotechnology from the University of Helsinki, Finland, on winning the Canon IXUS 40 Digital Camera in our Test the PAC-campaign. Congratulations!!